Physician

Rajinikanth Ayyathurai, M.D

According to 2025 Medicare claims, Rajinikanth Ayyathurai, M.D (NPI: 1700058351) practices urology in the Homosassa Springs, FL market, with the plurality of this provider's patient population coming from Citrus, FL. This provider's primary affiliated billing organization is ADVANCED UROLOGY INSTITUTE, LLC (NPI: 1023447935; TIN: 46-2439971) and primary practice location at 34461-8547.

Ayyathurai's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,015 traditional Medicare patients, billed 14,451 HCPCS/CPT codes, and received $751,122 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,786 prescription claims across 733 beneficiaries totaling $1,742,563 in drug costs, led by Xtandi (Enzalutamide). DME data shows 69 claims. Open Payments data shows 59 records totaling $1,483. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $146,655 to $751,122. Similarly, Part D prescription costs have risen steadily, from $52,052 to $1,742,563. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	401	2,802	$146,655
2016	564	5,208	$180,625
2017	587	3,929	$174,307
2018	602	3,778	$145,957
2019	706	6,795	$248,894
2020	681	7,534	$250,005
2021	882	11,681	$377,358
2022	1,026	13,217	$517,540
2023	1,024	16,226	$408,002
2024	1,015	14,451	$751,122

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	312	1,243	$52,052
2016	404	1,591	$75,126
2017	415	1,361	$68,552
2018	401	1,462	$134,698
2019	391	926	$96,037
2020	362	963	$197,134
2021	576	1,516	$339,318
2022	679	1,873	$398,488
2023	663	1,845	$433,732
2024	733	1,786	$1,742,563

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	36	$27,442
2016	N/R	43	$28,455
2017	12	124	$49,688
2018	13	151	$54,475
2019	13	148	$52,361
2020	12	73	$37,177
2021	N/R	57	$35,564
2022	N/R	66	$42,692
2023	12	82	$53,042
2024	12	69	$44,756

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	558	1,068	$97
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	525	698	$66
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	905	1,912	$13
51798	Ultrasound measurement of bladder capacity after voiding	457	690	$8
81003	Automated urinalysis test	846	1,801	$2

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Xtandi	Enzalutamide	73	2,190	$933,099
Erleada	Apalutamide	21	630	$235,665
Nubeqa	Darolutamide	12	360	$165,399
Orgovyx	Relugolix	42	1,256	$110,475
Myrbetriq	Mirabegron	86	6,105	$90,140

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4351	Intermittent urinary catheter; straight tip, with or without coating (teflon, silicone, silicone elastomer, or hydrophilic, etc.), each	N	12	51	$24,618
A4352	Intermittent urinary catheter; coude (curved) tip, with or without coating (teflon, silicone, silicone elastomeric, or hydrophilic, etc.), each	N	N/R	18	$20,138

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	59	$1,483	Dendreon Pharmaceuticals LLC
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Rajinikanth Ayyathurai, M.D?

Tedicare shows public-source Medicare data for Rajinikanth Ayyathurai, M.D (NPI 1700058351), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Rajinikanth Ayyathurai, M.D have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Rajinikanth Ayyathurai, M.D?

Rajinikanth Ayyathurai, M.D is linked to ADVANCED UROLOGY INSTITUTE, LLC (billing NPI 1023447935) in the available physician profile data.

Does Rajinikanth Ayyathurai, M.D have Open Payments data?

Rajinikanth Ayyathurai, M.D has 59 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.